NCT05542173View on ClinicalTrials.gov

Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Aphthous Stomatitis
Interventions
DRUG

BALI association

BALI association oral suspension, 25 mg + 25 mg + 15 mg, oral. Three applications per day or more in case of pain, not exceeding six applications per day.

DRUG

Placebo

Placebo. Three applications per day or more in case of pain, not exceeding six applications per day.

Trial Locations (1)

Unknown

EMS, Hortolândia

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY

NCT05542173 - Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations | Biotech Hunter | Biotech Hunter